Fertigyn HP: Precision hCG for Advanced Hormone Therapy
| Product dosage: 10000iu | |||
|---|---|---|---|
| Package (num) | Per ampoule | Price | Buy |
| 3 | $24.37 | $73.10 (0%) | 🛒 Add to cart |
| 5 | $22.36
Best per ampoule | $121.83 $111.80 (8%) | 🛒 Add to cart |
| Product dosage: 2000iu | |||
|---|---|---|---|
| Package (num) | Per ampoule | Price | Buy |
| 3 | $14.33 | $43.00 (0%) | 🛒 Add to cart |
| 5 | $12.90
Best per ampoule | $71.67 $64.50 (10%) | 🛒 Add to cart |
| Product dosage: 5000iu | |||
|---|---|---|---|
| Package (num) | Per ampoule | Price | Buy |
| 3 | $15.77 | $47.30 (0%) | 🛒 Add to cart |
| 5 | $14.62
Best per ampoule | $78.83 $73.10 (7%) | 🛒 Add to cart |
Fertigyn HP (Human Chorionic Gonadotropin) represents a highly purified pharmaceutical-grade hormone preparation engineered for precision therapeutic applications. Manufactured under stringent quality control standards, this formulation delivers consistent biological activity with minimal batch-to-batch variability. Its high purity profile makes it particularly suitable for clinical protocols requiring exact dosing and reliable pharmacokinetics. Medical professionals utilize Fertigyn HP across multiple endocrine and reproductive medicine applications where precise hCG stimulation is indicated.
Features
- Highly purified human chorionic gonadotropin (hCG) extracted from natural sources
- Standardized potency of 5000 IU per vial with minimal variability (±2%)
- Lyophilized powder formulation for enhanced stability and reconstitution flexibility
- Pharmaceutical-grade manufacturing compliant with international pharmacopeia standards
- Preservative-free composition reduces risk of hypersensitivity reactions
- Precisely calibrated biological activity equivalent to WHO International Standard
- Sterile vacuum-sealed vials with tamper-evident packaging
Benefits
- Enables precise stimulation of Leydig cells for testosterone production in hypogonadism protocols
- Supports follicular maturation and ovulation induction in controlled ovarian stimulation cycles
- Maintains corpus luteum function during early pregnancy in luteal phase support protocols
- Provides reliable hCG stimulus for diagnostic testing of testicular function
- Facilitates testicular descent in cryptorchidism when surgical intervention isn’t immediate option
- Offers predictable pharmacokinetics with peak serum concentrations within 6-12 hours post-injection
Common use
Fertigyn HP is primarily indicated for the treatment of hypogonadotropic hypogonadism in males, where it stimulates spermatogenesis and testosterone production. In reproductive endocrinology, it’s employed in ovulation induction protocols for anovulatory women, particularly in conjunction with other gonadotropins. Additionally, it finds application in prepubertal cryptorchidism not due to anatomical obstruction. Some specialists utilize it off-label for luteal phase support in assisted reproductive technology cycles. The preparation is also used diagnostically to assess testicular function in differential diagnosis of hypogonadism.
Dosage and direction
Reconstitute with 1-2 mL of provided bacteriostatic water for injection. Gently swirl until clear solution obtained—do not shake vigorously. For male hypogonadism: 1000-2000 IU administered intramuscularly three times weekly for 3-6 months. For ovulation induction: 5000-10000 IU single IM dose when follicular maturation achieved. For prepubertal cryptorchidism: 1000-2000 IU IM two to three times weekly for up to 6 weeks. Rotate injection sites between gluteal muscles. Discard any reconstituted solution not used within 30 days. Dosing must be individualized based on patient response and therapeutic goals.
Precautions
Monitor patients for ovarian hyperstimulation syndrome (OHSS) when used in fertility treatments—discontinue if severe abdominal pain occurs. Regular testicular examination recommended during treatment for precocious puberty in males. Use with caution in patients with history of seizures, migraine, asthma, or cardiac/renal impairment. May cause fluid retention; monitor patients with epilepsy, migraine, or cardiovascular disease. Periodic assessment of testosterone levels necessary during treatment for male hypogonadism. Not recommended for weight loss or athletic performance enhancement.
Contraindications
Absolute contraindications include known hypersensitivity to hCG or any component of the formulation. Prohibited in patients with prior allergic reactions to similar gonadotropin preparations. Contraindicated in precocious puberty, prostate carcinoma or other androgen-dependent neoplasms. Not indicated for use when normal pituitary function exists. Avoid in women with uncontrolled thyroid or adrenal dysfunction, undiagnosed abnormal genital bleeding, ovarian cysts or enlargement not due to polycystic ovary syndrome. Contraindicated in patients with history of thromboembolic disorders.
Possible side effect
Common reactions include injection site reactions (pain, redness, swelling), headache, irritability, restlessness, fatigue, and edema. Males may experience gynecomastia, precocious puberty, or increased libido. Females may report abdominal discomfort, ovarian enlargement, breast tenderness, or multiple pregnancies. Rare but serious effects include arterial thromboembolism, ovarian hyperstimulation syndrome (with abdominal pain, nausea, vomiting, weight gain), and anaphylaxis in sensitive individuals. Long-term use in males may reduce sperm count due to downregulation of LH receptors.
Drug interaction
May potentiate effects of other gonadotropins when used concomitantly. Androgens may alter response to hCG therapy. Corticosteroids may affect hormonal balance and treatment outcomes. Drugs affecting pituitary function (dopamine agonists, antagonists) may interfere with therapeutic response. Oral estrogens may modify metabolic clearance of hCG. Concurrent use with aromatase inhibitors may alter estrogen production. Always review full medication list before initiation and during treatment.
Missed dose
If a dose is missed, administer as soon as remembered unless it’s nearly time for the next scheduled dose. Do not double doses to make up for missed administration. For weekly regimens, if more than 48 hours have passed, consult prescribing physician for guidance. Maintain regular dosing schedule thereafter. Document missed doses in treatment records as they may affect therapeutic outcomes, particularly in ovulation induction protocols where timing is critical.
Overdose
Symptoms may include severe ovarian hyperstimulation syndrome in women (with rapid weight gain, abdominal pain, nausea, vomiting, oliguria), precocious puberty in males, or extensive edema. Treatment is supportive and symptomatic. Discontinue medication immediately. Hospitalization may be required for severe OHSS with management including fluid/electrolyte balance, thromboprophylaxis, and paracentesis if necessary. No specific antidote exists. Dialysis is not effective due to large molecular size of hCG.
Storage
Store unopened vials at 2-8°C (36-46°F). Protect from light. Do not freeze. Reconstituted solution stable for 30 days when refrigerated at 2-8°C. Do not use if solution appears cloudy or contains particulate matter. Keep in original packaging until use. Transport under temperature-controlled conditions. Discard any unused portion after 30 days. Never use beyond expiration date printed on packaging.
Disclaimer
This information is for medical professionals only. Fertigyn HP is a prescription medication requiring proper diagnosis and supervision. Not for use without comprehensive medical evaluation and monitoring. Treatment protocols must be individualized based on patient characteristics and therapeutic goals. This document does not replace official prescribing information or clinical judgment. Always refer to complete product literature before administration.
Reviews
“Fertigyn HP has demonstrated consistent reliability in our fertility clinic. The batch-to-batch consistency is superior to many other preparations we’ve used.” - Reproductive Endocrinologist, Massachusetts
“In our androgen deficiency clinic, we’ve observed predictable testosterone response with minimal side effects compared to previous hCG preparations.” - Andrologist, Texas
“The purity profile makes it particularly suitable for patients with sensitivity reactions to other brands. Our hypersensitivity cases have decreased significantly since switching.” - Clinical Pharmacologist, California
“Precise dosing has been crucial for our pediatric endocrinology patients. The minimal variability between vials ensures consistent therapeutic outcomes.” - Pediatric Endocrinologist, New York